Ardsley Advisory Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-25,000
| Closed | -$553K | – | 120 |
|
|
2019
Q2 | $553K | Sell |
25,000
-25,000
| -50% | -$553K | 0.09% | 73 |
|
|
2019
Q1 | $682K | Buy |
50,000
+35,000
| +233% | +$477K | 0.13% | 60 |
|
|
2018
Q4 | $136K | Hold |
15,000
| – | – | 0.03% | 85 |
|
|
2018
Q3 | $248K | Hold |
15,000
| – | – | 0.03% | 117 |
|
|
2018
Q2 | $210K | Sell |
15,000
-15,000
| -50% | -$210K | 0.03% | 128 |
|
|
2018
Q1 | $332K | Buy |
+30,000
| New | +$332K | 0.05% | 112 |
|